MaaT Pharma Overview

  • Founded
  • 2014
Founded
  • Status
  • Public
  • Employees
  • 39
Employees
  • Stock Symbol
  • MAAT
Stock Symbol
  • Share Price
  • $10.87
  • (As of Monday Closing)

MaaT Pharma General Information

Description

Maat Pharma SA is a french clinical stage biotech and a pioneer in the development of microbiome based ecosystem therapies dedicated to improving survival outcomes for patients with cancer.

Contact Information

Website
www.maatpharma.com
Ownership Status
Publicly Held
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Stock Exchange
PAR
Primary Office
  • 70 Avenue Tony Garnier
  • 69007 Lyon
  • France
+33 04 00 00 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

MaaT Pharma Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$10.87 $12.40 $10.33 - $16.66 $123M 9.9M 1.46K -$0.90

MaaT Pharma Financials Summary

In Thousands,
USD 		TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
Revenue 459 0 0 0
EBITDA (8,168) (5,804) (6,411) (5,104)
Net Income (8,559) (6,043) (6,542) (5,281)
Total Assets 26,121 29,859 9,152 6,732
Total Debt 7,046 7,473 11,723 2,976
Public Fundamental Data provided by Morningstar, Inc. disclaimer

MaaT Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore MaaT Pharma‘s full profile, request access.

Request a free trial

MaaT Pharma Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion
Price		 % Owned

This information is available in the PitchBook Platform. To explore MaaT Pharma‘s full profile, request access.

Request a free trial

MaaT Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Maat Pharma SA is a french clinical stage biotech and a pioneer in the development of microbiome based ecosystem therapi
Drug Discovery
Lyon, France
39 As of 2021
000.00
0000 0000-00-00
00000000 000.00

00000 00

elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, q
0000 000000000
Woburn, MA
00 As of 0000
00000
0000 0000-00-00
00000000000 00000

00000 00

am, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute iru
0000000000000
Cambridge, MA
00 As of 0000
00000
000000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MaaT Pharma Competitors (16)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Axial Therapeutics Venture Capital-Backed Woburn, MA 00 00000 00000000000 00000
00000 00000000000 Formerly VC-backed Cambridge, MA 00 00000 000000000 00000
00000 (0000 000000 Formerly VC-backed Somerville, MA 000 00000 00000000 00000
00000 000000000000 Formerly VC-backed Cambridge, MA 000 00000 000000000 00000
00000000 Venture Capital-Backed Paris, France 00 00000 00000000000 00000
You’re viewing 5 of 16 competitors. Get the full list »

MaaT Pharma Patents

  • 38

    Total Documents Applications and Grants

  • 000

    Total Patents Families

  • 4

    Granted

  • 2

    Pending

  • 000

    Expiring in next 12 mo

MaaT Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3895716-A1 Fmt performance prediction test to guide and optimize therapeutic management of gvhd patients Pending 17-Apr-2020 000000000 0
EP-3895716-A4 Fmt performance prediction test to guide and optimize therapeutic management of gvhd patients Pending 17-Apr-2020 000000000
CA-3112517-A1 Lyophilisation container Pending 27-Sep-2018 00000000
EP-3857146-A1 Lyophilisation container Pending 27-Sep-2018 00000000
FR-3086739-A1 Lyophilization container Granted 27-Sep-2018 F26B5/06 0
To view MaaT Pharma’s complete patent history, request access »

MaaT Pharma Executive Team (12)

Name Title Board Seat Contact Info
Herve Affagard Co-Founder, Chief Executive Officer & Board Member
Siân Crouzet Chief Operating Officer & Chief Financial Officer
Carole Schwintner Chief Technology Officer
Savita Bernal Chief Business Officer
Mohamad Mohty MD Co-Founder & Medical Haematology-Oncology Advisor
You’re viewing 5 of 12 executive team members. Get the full list »

MaaT Pharma Board Members (13)

Name Representing Role Since
Chidozie Ugwumba SymBiosis Capital Management Board Member 000 0000
Claude Bertrand MaaT Pharma Board Member 000 0000
Herve Affagard MaaT Pharma Co-Founder, Chief Executive Officer & Board Member 000 0000
Isabelle de Cremoux Seventure Partners Board Member 000 0000
Jean-Marie Lefevre MaaT Pharma Chairman of the Board 000 0000
You’re viewing 5 of 13 board members. Get the full list »

MaaT Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MaaT Pharma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore MaaT Pharma‘s full profile, request access.

Request a free trial